The center’s launch in 2012 turned a long‑standing gap in cardiovascular research into a concrete resource for women.
More than 500,000 women die each year in the U.S. from heart disease, a figure that eclipses all cancer deaths combined. Yet for decades, clinical trials and imaging tools were built around male anatomy, leaving female patients with symptoms that looked different and were often misdiagnosed.
Microvascular coronary dysfunction—blockage of the tiny arteries that feed the heart—shows up in women as pressure, indigestion, breathlessness, or fatigue rather than the classic chest‑tightening seen in men. Standard angiograms miss these subtle changes, which is why the center pioneered adenosine cardiac magnetic‑resonance imaging, a test that visualizes blood flow in the smallest vessels.
Dr. Noel Bairey‑Merz, the medical director, explained that the new imaging can catch disease early, when lifestyle tweaks and medication can still reverse the damage. “If a woman reports feeling unusually short‑of‑breath or a vague pressure in her chest, we can use this test to see if her micro‑arteries are compromised,” she said.
The $10 million gift also helped attract other high‑profile donors, raising more than $22 million for women‑specific research. This private funding has kept studies running even when public grants are scarce, accelerating the development of treatment protocols that account for hormonal and anatomical differences.
For readers, the take‑away is simple: if you’re a woman with chest pressure, indigestion, or unexplained fatigue, ask your cardiologist about microvascular testing. Early detection can lead to personalized therapies that dramatically improve survival and quality of life. However, always consult a qualified professional before starting new treatments.